Cargando…
Cardiomyopathy Associated with Anti-SARS-CoV-2 Vaccination: What Do We Know?
The SARS-CoV-2 pandemic has mobilized many efforts worldwide to curb its impact on morbidity and mortality. Vaccination of the general population has resulted in the administration of more than 6,700,000,000 doses by the end of October 2021, which is the most effective method to prevent hospitalizat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708989/ https://www.ncbi.nlm.nih.gov/pubmed/34960761 http://dx.doi.org/10.3390/v13122493 |